Original Articles
Open label tissue plasminogen activator for stroke: The Oregon experience*

https://doi.org/10.1016/S1052-3057(99)80001-9Get rights and content

Abstract

Background: Tissue plasminogen activator (t-PA) is the first effective treatment for stroke. This study sought to explore the outcome of patients treated with t-PA in the community after approval of its use in the treatment of stroke in June, 1996. Methods: All patients with acute stroke within the 6-hospital Oregon Stroke Center network were screened for potential t-PA treatment. Baseline and 24-hour outcome assessments were performed with the use of the National Institutes of Health Stroke Scale (NIHSS) and computed tomography (CT); 3-month outcome was evaluated by using the Modified Rankin scale. Results: Thirty-three patients who met the criteria for t-PA therapy were treated within 3 hours of symptom onset. All but 2 strokes were in the anterior circulation; 48.5% were cardioembolic. The NIHSS scores at 24 hours after administration of t-PA (mean, 14.7) showed modest gains from baseline NIHSS scores (mean, 16.6). Twelve patients (36%) had minimal or no deficits at 3 months. Three patients (9%), all of whom had baseline NIHSS scores of 20 or more, had symptomatic intracranial hemorrhages, 2 of which were fatal (6%). Conclusion: This study shows the feasibility of treating acute stroke with t-PA in the community. The percentage of fully recovered patients at 3 months mirrored those in the National Institute of Neurologic Disorders and Stroke (NINDS) trial.

References (14)

  • American College of Physicians and the Investigators of the PORT Study

    Guidelines for medical treatment for stroke prevention

    Ann Intern Med

    (1994)
  • C Fieschi et al.

    Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours

    J Neurol Sci

    (1989)
  • T Brandt et al.

    Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome

    Stroke

    (1996)
  • VJ Marder et al.

    Thrombolytic Therapy: Current status

    N Engl J Med

    (1998)
  • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group

    Tissue plasminogen activator for acute ischemic stroke

    N Engl J Med

    (1995)
  • The European Cooperative Acute Stroke Study

    Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke

    JAMA

    (1995)
  • HL Lutsep et al.

    Acute stroke therapy: Perspectives on current, future treatments

    Formulary

    (1997)
There are more references available in the full text version of this article.

Cited by (0)

*

Address reprint requests to Helmi L. Lutsep, MD, Oregon Stroke Center, Oregon Health Sciences University, Mail Code CR-131, 3181 SW Sam Jackson Park Road, Portland, OR 97201.

View full text